177 related articles for article (PubMed ID: 37999374)
1. Novel Approach for Obtaining Variable Domain of New Antigen Receptor with Different Physicochemical Properties from Japanese Topeshark (
Nakada-Masuta T; Takeda H; Uchida K
Mar Drugs; 2023 Oct; 21(11):. PubMed ID: 37999374
[TBL] [Abstract][Full Text] [Related]
2. VNAR development through antigen immunization of Japanese topeshark (
Takeda H; Ozawa T; Zenke H; Ohnuki Y; Umeda Y; Zhou W; Tomoda H; Takechi A; Narita K; Shimizu T; Miyakawa T; Ito Y; Sawasaki T
Front Bioeng Biotechnol; 2023; 11():1265582. PubMed ID: 37771574
[TBL] [Abstract][Full Text] [Related]
3. Isolation and Characterization of Targeting-HBsAg VNAR Single Domain Antibodies from Whitespotted Bamboo Sharks (
Jiang X; Sun S; Li Z; Chen M
Mar Drugs; 2023 Apr; 21(4):. PubMed ID: 37103376
[TBL] [Abstract][Full Text] [Related]
4. Construction and next-generation sequencing analysis of a large phage-displayed V
Feng M; Bian H; Wu X; Fu T; Fu Y; Hong J; Fleming BD; Flajnik MF; Ho M
Antib Ther; 2019 Jan; 2(1):1-11. PubMed ID: 30627698
[No Abstract] [Full Text] [Related]
5. Identification of Anti-TNFα VNAR Single Domain Antibodies from Whitespotted Bambooshark (
Zhao L; Chen M; Wang X; Kang S; Xue W; Li Z
Mar Drugs; 2022 Apr; 20(5):. PubMed ID: 35621957
[TBL] [Abstract][Full Text] [Related]
6. Antigen specific VNAR screening in whitespotted bamboo shark (Chiloscyllium plagiosum) with next generation sequencing.
Zhong B; Sun S; Luo Z; Yang J; Jia L; Zheng K; Tang W; Jiang X; Lyu Z; Chen J; Chen G
Fish Shellfish Immunol; 2024 Jul; 150():109661. PubMed ID: 38821227
[TBL] [Abstract][Full Text] [Related]
7. Generation of VNAR Libraries from Immunized Sharks and Selection of Target-Specific Clones.
Dooley H
Methods Mol Biol; 2022; 2421():57-72. PubMed ID: 34870811
[TBL] [Abstract][Full Text] [Related]
8. Isolation and characterization of malaria PfHRP2 specific V
Leow CH; Fischer K; Leow CY; Braet K; Cheng Q; McCarthy J
Malar J; 2018 Oct; 17(1):383. PubMed ID: 30355309
[TBL] [Abstract][Full Text] [Related]
9. Isolation of highly selective IgNAR variable single-domains against a human therapeutic Fc scaffold and their application as tailor-made bioprocessing reagents.
Buschhaus MJ; Becker S; Porter AJ; Barelle CJ
Protein Eng Des Sel; 2019 Dec; 32(9):385-399. PubMed ID: 32119084
[TBL] [Abstract][Full Text] [Related]
10. Generation of Semi-Synthetic Shark IgNAR Single-Domain Antibody Libraries.
Grzeschik J; Könning D; Hinz SC; Krah S; Schröter C; Empting M; Kolmar H; Zielonka S
Methods Mol Biol; 2018; 1701():147-167. PubMed ID: 29116504
[TBL] [Abstract][Full Text] [Related]
11. Ancient species offers contemporary therapeutics: an update on shark V
English H; Hong J; Ho M
Antib Ther; 2020 Jan; 3(1):1-9. PubMed ID: 32118195
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic and therapeutic potential of shark variable new antigen receptor (VNAR) single domain antibody.
Cheong WS; Leow CY; Abdul Majeed AB; Leow CH
Int J Biol Macromol; 2020 Mar; 147():369-375. PubMed ID: 31926922
[TBL] [Abstract][Full Text] [Related]
13. Phage Display Derived IgNAR V Region Binding Domains for Therapeutic Development.
Ubah OC; Barelle CJ; Buschhaus MJ; Porter AJ
Curr Pharm Des; 2016; 22(43):6519-6526. PubMed ID: 27604606
[TBL] [Abstract][Full Text] [Related]
14. Exploring shark VNAR antibody against infectious diseases using phage display technology.
Lim HT; Kok BH; Leow CY; Leow CH
Fish Shellfish Immunol; 2023 Sep; 140():108986. PubMed ID: 37541634
[TBL] [Abstract][Full Text] [Related]
15. Selection, identification and crystal structure of shark-derived single-domain antibodies against a green fluorescent protein.
Chen YL; Xie XX; Zheng P; Zhu C; Ma H; Khalid Z; Xie YJ; Dang YZ; Ye Y; Sheng N; Zhong N; Lei WH; Zhang C; Zhang LJ; Jin T; Cao MJ
Int J Biol Macromol; 2023 Aug; 247():125852. PubMed ID: 37460076
[TBL] [Abstract][Full Text] [Related]
16. Single domain shark VNAR antibodies neutralize SARS-CoV-2 infection in vitro.
Gauhar A; Privezentzev CV; Demydchuk M; Gerlza T; Rieger J; Kungl AJ; Walsh FS; Rutkowski JL; Stocki P
FASEB J; 2021 Nov; 35(11):e21970. PubMed ID: 34637549
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of SARS-CoV-2 neutralization by shark variable new antigen receptors elucidated through X-ray crystallography.
Ubah OC; Lake EW; Gunaratne GS; Gallant JP; Fernie M; Robertson AJ; Marchant JS; Bold TD; Langlois RA; Matchett WE; Thiede JM; Shi K; Yin L; Moeller NH; Banerjee S; Ferguson L; Kovaleva M; Porter AJ; Aihara H; LeBeau AM; Barelle CJ
Nat Commun; 2021 Dec; 12(1):7325. PubMed ID: 34916516
[TBL] [Abstract][Full Text] [Related]
18. Improving the pharmacokinetic properties of biologics by fusion to an anti-HSA shark VNAR domain.
Müller MR; Saunders K; Grace C; Jin M; Piche-Nicholas N; Steven J; O'Dwyer R; Wu L; Khetemenee L; Vugmeyster Y; Hickling TP; Tchistiakova L; Olland S; Gill D; Jensen A; Barelle CJ
MAbs; 2012; 4(6):673-85. PubMed ID: 23676205
[TBL] [Abstract][Full Text] [Related]
19. Overview, Generation, and Significance of Variable New Antigen Receptors (VNARs) as a Platform for Drug and Diagnostic Development.
Pandey SS; Kovaleva M; Barelle CJ; Ubah OC
Methods Mol Biol; 2022; 2446():19-33. PubMed ID: 35157267
[TBL] [Abstract][Full Text] [Related]
20. The influence of antibody humanization on shark variable domain (VNAR) binding site ensembles.
Fernández-Quintero ML; Fischer AM; Kokot J; Waibl F; Seidler CA; Liedl KR
Front Immunol; 2022; 13():953917. PubMed ID: 36177031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
